George I. Papakostas, MD, is Associate Professor of Psychiatry at Harvard Medical School and Director of Treatment-Resistant Depression Studies in the Department of Psychiatry at Massachusetts General Hospital in Boston, Massachusetts. He is also field editor for Psychopharmacology for the “World Journal of Biological Psychiatry” and is on the editorial boards of “The Journal of Clinical Psychiatry” and “Psychiatry Research.”

The focus of Dr. Papakostas’s research includes the pharmacotherapy of major depressive disorder including treatment-resistant depression, the study of the “placebo” effect and it’s relevance to clinical trial design in major depressive disorder, and the study of clinical and biologic predictors, moderators, and mediators of treatment outcome in major depressive disorder. Dr. Papakostas has received numerous national and international research awards from sources including the American College of Neuropsychopharmacology, the Collegium Internationale Neuropsychopharmacologium, the New Clinical Drug Evaluation Unit of the National Institute of Mental Health, the American Psychiatric Association, the World Federation of Societies of Biological Psychiatry, the American Academy of Clinical Psychiatrists, the International College of Psychosomatic Medicine, and the American Foundation for Suicide Prevention.

Dr. Papakostas is author or co-author of over 150 clinical and scientific publications and book chapters, and is author of the book entitled: “Pharmacotherapy for Depression” (World Scientific Publishing and Imperial College Press). Dr. Papakostas is often invited throughout the United States and abroad to lecture on a wide range topics pertaining to the treatment of depression. To date, he has delivered more than 100 lectures at National or International meetings in more than 30 countries.